Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISTINCT study of oral desmopressin for nocturnal polyuria and slow-wave sleep
jRCTs051190080Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of desmopressin in nocturnal polyuria (NP) and nocturia, sponsored by Ferring Pharmaceuticals. Primary endpoint: Change in slow-wave sleep time. Started Jan 2020; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal polyuria (NP)nocturia
Beyond the preview
Go deeper on jRCTs051190080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190080.